RxDoctor Payments DataLook up a doctor →

Lucentis: payments to doctors

Payments that named Lucentis as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$14.6M
Providers
2,616
Transactions
11,450
Average per transaction
$1,277

The per-transaction average — $1,277 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,616 providers the average total is $5,589, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Genentech, Inc.$10,386,29171.0%
Genentech USA, Inc.$3,874,99626.5%
F. Hoffmann-la Roche AG$358,1652.4%
Novartis$1240.0%
← All drugs & devices